|
Delayed
London S.E.
06:03:22 2026-10-29 EDT
|
5-day change | 1st Jan Change | ||
| 5.575 GBX | -0.45% |
|
-3.88% | -5.51% |
| 10-28 | Renalytix Plc Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| 10-28 | Earnings Flash (RENX.L) Renalytix plc Reports FY26 Revenue $3.0M | MT |
Company Valuation: Renalytix Plc
Data adjusted to current consolidation scope
| Fiscal Period: June | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 389.9 | 1,077 | 95.39 | 134.1 | 21.46 | 32.9 |
| Change | - | 176.19% | -91.14% | 40.56% | -83.99% | 53.3% |
| Enterprise Value (EV) 1 | 376.3 | 1,012 | 66.4 | 121.5 | 25.31 | 37.5 |
| Change | - | 168.91% | -93.44% | 83.01% | -79.17% | 48.13% |
| P/E | -41.9x | -30.7x | -1.92x | -2.58x | -0.45x | -1.34x |
| PBR | 10.8x | 15.1x | 3.12x | 19.2x | -2.73x | -4.7x |
| PEG | - | -0x | -0.1x | 0.2x | 0x | 0x |
| Capitalization / Revenue | - | 722,268,086x | 32,116,721x | 39,398,762x | 9,375,188x | 10,966,084x |
| EV / Revenue | - | - | - | - | - | - |
| EV / EBITDA | -38x | -31x | -1.25x | -2.9x | -0.88x | -2.23x |
| EV / EBIT | -34x | -30.8x | -1.25x | -2.88x | -0.88x | -2.21x |
| EV / FCF | -48x | -61.9x | -2.17x | -7.02x | -1.3x | -3.34x |
| FCF Yield | -2.09% | -1.61% | -46% | -14.2% | -76.9% | -30% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.1566 | -0.4858 | -0.666 | -0.5548 | -0.31 | -0.0743 |
| Distribution rate | - | - | - | - | - | - |
| Net sales | - | 1.491 | 2.97 | 3.403 | 2.289 | 3 |
| EBITDA 1 | -9.892 | -32.69 | -53.01 | -41.93 | -28.62 | -16.8 |
| EBIT 1 | -11.08 | -32.89 | -53.3 | -42.24 | -28.88 | -17 |
| Net income 1 | -9.25 | -34.72 | -45.28 | -45.61 | -33.46 | -20.4 |
| Net Debt 1 | -13.65 | -65.13 | -28.99 | -12.56 | 3.855 | 4.6 |
| Reference price 2 | 6.5623 | 14.9161 | 1.2759 | 1.4296 | 0.1390 | 0.0993 |
| Nbr of stocks (in thousands) | 59,416 | 72,197 | 74,760 | 93,781 | 154,368 | 331,206 |
| Announcement Date | 10/20/20 | 10/21/21 | 10/31/22 | 9/28/23 | 9/30/24 | 11/4/25 |
1USD in Million2USD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 45.01M | |
| 36.06x | 6.09x | 23.28x | 0.26% | 260B | |
| 37.21x | 7.05x | 22.09x | 0.62% | 165B | |
| 51.2x | 12.41x | 26.62x | -.--% | 154B | |
| 16.67x | 3.37x | 10.92x | -.--% | 61.49B | |
| 36.38x | 7.29x | 23.05x | -.--% | 52.9B | |
| 20.86x | 2.49x | 12.59x | 2.42% | 52.84B | |
| 48.66x | 12.03x | 26.52x | -.--% | 51.46B | |
| 35.36x | 7x | 23.77x | 0.57% | 51.16B | |
| 83.48x | 7.91x | 24.03x | -.--% | 46.85B | |
| Average | 40.65x | 7.29x | 21.43x | 0.43% | 89.58B | |
| Weighted average by Cap. | 39.83x | 7.51x | 22.39x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- RENX Stock
- Valuation Renalytix Plc
Select your edition
All financial news and data tailored to specific country editions
